IGF1R and cancer: This notion is supported by a recent study that tumor OPCs existed as the cancer stem cells in human GBMs and may function to resist to therapy.[44] More work should be done to further stratify GBMs to determine the suitable patients with the best prognosis with IGF1R targeted therapy.